Bausch Health
BHC
#4720
Rank
NZ$3.51 B
Marketcap
NZ$9.47
Share price
1.12%
Change (1 day)
-0.34%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): NZ$1.65

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is NZ$1.70. In 2024 the company made an earnings per share (EPS) of NZ-$0.21 an increase over its 2023 EPS that were of NZ-$2.83.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$1.65-883.78%
2024NZ-$0.21-92.59%
2023NZ-$2.83160.89%
2022NZ-$1.09-76.64%
2021NZ-$4.6568.45%
2020NZ-$2.76-68.91%
2019NZ-$8.88-57.11%
2018NZ-$20.71-272.22%
2017NZ$12.02-199.29%
2016NZ-$12.11798.7%
2015NZ-$1.35-128.31%
2014NZ$4.76-204.62%
2013NZ-$4.55602.7%
2012NZ-$0.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
NZ-$0.42-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ-$1.66-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA